Export potential of the pharmaceutical industry (review)
https://doi.org/10.33380/2305-2066-2025-14-4-2203
Abstract
Introduction. Bringing medicines for medical use to the market is an extremely expensive and resource-intensive process associated with long-term development, high risks, quality assurance of the final product, safety and efficiency, while limited by strict regulatory requirements. The key goals of the pharmaceutical industry development are to promote the conditions for guaranteeing the safety of the Russian Federation in the field of drug provision to the population and drug availability in all segments, ensuring an advanced level of scientific, technical and technological development of the pharmaceutical industry, creating an export-oriented potential, the presence of competencies in research and development, full-cycle production, implementation in clinical practice and export of medicines. The development of the pharmaceutical and medical industry of the Russian Federation involves not only a consistently pursued import substitution policy, but also the task of realizing the export potential to ensure comprehensive support for the stability of the national pharmaceutical market.
Text. The article demonstrates data on the export of Russian medicines, suggests possible methods and tools for reducing barriers to entering foreign markets and supporting the export activities of domestic manufacturers.
Conclusion. The main areas of implementation of the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation until 2030 provide for support for the export of Russian pharmaceutical products. The application of the system for assessing the levels of readiness of export potential will allow it to be used as a tool for reducing barriers to entry into foreign markets and strengthening the positions of Russian manufacturers, including ensuring harmonization of regulation with the best international practices.
About the Authors
V. N. Shestakov
Federal State Institution "State Institute of Drugs and Good Practices"
Russian Federation
Russian Federation
9, Leninsky prospekt, Moscow, 119049
N. V. Pyatigorskaya
I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
8/2, Trubetskaya str., Mosсow, 119991
References
1. Gerschewski S., Scott-Kennel J., Rose E. L. Ready to export? The role of export readiness for superior export performance of small and medium-sized enterprises. The World Economy. 2020;43(5):1253–1276. DOI: 10.1111/twec.12928.
2. Tan A., Brewer P., Liesch P. W. Before the first export decision: Internationalisation readiness in the pre-export phase. International Business Review. 2007;16(3):294–309. DOI: 10.1016/j.ibusrev.2007.01.001.
3. Ilinski K. Learning Your Options: Option-Based Model of Export Readiness and Optimal Export. Entropy (Basel). 2022;24(2):173. DOI: 10.3390/e24020173.
4. Labanca C., Molina D., Muendler M.-A. Preparing for export opportunities. Journal of International Economics. 2024;152:103968. DOI: 10.1016/j.jinteco.2024.103968.
5. Meshkovskiy A. P., Pyatigorskaya N. V., Aladysheva Zh. I., Beregovykh V. V., Pyatigorskiy A. M., Nikolenko N. S., Marshalova M. M., Belyaev V. V. Obligations of holders of registration certificates regarding compliance with GMP regulations. Drug development & registration. 2020;9(4):15–20. (In Russ.) DOI: 10.33380/2305-2066-2020-9-4-164-170.
6. Meshechkina R. P., Ustinova E. M., Naumov A. A. Statistical assessment of Russia's foreign trade and prospects for its development based on cooperation with BRICS countries. Vestnik Belgorodskogo universiteta kooperatsii, ekonomiki i prava. 2025;1(110):31–41. (In Russ.) DOI: 10.21295/2223-5639-2025-1-31-41.
7. Aladysheva Zh. A., Beregovykh V. V., Meshkovskiy A. P., Pyatigorskaya N. V. Refinement of Drug Regulation and Russian Pharmaceutical Export. Federalism. 2023;28(4):157–183. (In Russ.) DOI: 10.21686/2073-1051-2023-4-157-183.
8. Aladysheva Z. A., Beregovykh V. V., Meshkovskiy A. P., Pyatigorskaya N. V. Drug Regulation in Top Exporters of Pharmaceutical Products. Federalism. 2023;28(3):108–136. (In Russ.) DOI: 10.21686/2073-1051-2023-3-108-136.
9. Petrov A. N., Sartory A. V., Filimonov A. V. Comprehensive assessment of the status scientific and technical projects using Technology Project Readiness Level. Economics of Science. 2016;2(4):244–260. (In Russ.)
10. Komarov A. V., Matveev D. A., Filimonov A. V., Sartory A. V. On the development of mechanisms and tools for expanding the value of full-cycle science and technology projects using the TPRL methodology. Economics of Science. 2018;4(4):282–296. (In Russ.) DOI: 10.22394/2410-132X-2018-4-4-282-296.
11. Lowe D. C., Justham L., Everitt M. J. Multi-index analysis with readiness levels for decision support in product design. Technological Forecasting and Social Change. 2024;206:123559. DOI: 10.1016/j.techfore.2024.123559.
12. Kedia S. B., Baker J. C., Carbonell R. G., Lee K. H., Roberts C. J., Erickson J., Schiel J. E., Rogers K., Schaefer G., Pluschkell S. Biomanufacturing readiness levels [BRL]-A shared vocabulary for biopharmaceutical technology development and commercialization. Biotechnology and Bioengineering. 2022;119(12):3526–3536. DOI: 10.1002/bit.28227.
13. Smanski M. J., Aristidou A., Carruth R., Erickson J., Gordon M., Kedia S. B., Lee K. H., Prather D., Schiel J. E., Schultheisz H., Treynor T. P., Evans S. L., Friedman D. C., Tomczak M. Bioindustrial manufacturing readiness levels (BioMRLs) as a shared framework for measuring and communicating the maturity of bioproduct manufacturing processes. Journal of Industrial Microbiology and Biotechnology. 2022;49(5):kuac022. DOI: 10.1093/jimb/kuac022.
14. Miller M. E., Thomas S., Rusnock C. Extending System Readiness Levels to Assess and Communicate Human Readiness. Systems Engineering. 2016;19(2):146–157. DOI: 10.1002/sys.21344.
15. Pyatigorskiy A. M., Brkich G. E., Beregovykh V. V., Pyatigorskaya N. V., Zyryanov O. A., Kuznetsov A. O. System for assessing production readiness levels of pharmaceutical products. Herald of the Russian Academy of Medical Sciences. 2025;80(2):138–145. (In Russ.) DOI: 10.15690/vramn18036.
16. Yfanti S., Sakkas N. Technology Readiness Levels (TRLs) in the Era of Co-Creation. Applied System Innovation. 2024;7(2):32. DOI: 10.3390/asi7020032.
17. Salvador-Carulla L., Woods C., de Miquel C., Lukersmith S. Adaptation of the technology readiness levels for impact assessment in implementation sciences: The TRL-IS checklist. Heliyon. 2024;10(9):e29930. DOI: 10.1016/j.heliyon.2024.e29930.
18. Pyatigorsky A. M., Brkich G. E., Beregovykh V. V., Pyatigorskaya N. V. Comprehensive assessment of technological readiness of an innovative project during the development of a pharmaceutical product. Annals of the Russian Academy of Medical Sciences. 2023;78(3):234–241. (In Russ.) DOI: 10.15690/vramn8349.
19. Pyatigorsky A. M., Brkich G. E., Beregovykh V. V., Pyatigorskaya N. V., Zyryanov O. A., Kuznetsov A. O. Pharmaceutical product manufacturing readiness levels. Annals of the Russian Academy of Medical Sciences. 2025;80(2):138–145. (In Russ.) DOI: 10.15690/vramn18036.
Supplementary files
|
|
1. Графический абстракт | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(1MB)
|
Indexing metadata ▾ | |
Review
For citations:
Shestakov V.N., Pyatigorskaya N.V. Export potential of the pharmaceutical industry (review). Drug development & registration. (In Russ.) https://doi.org/10.33380/2305-2066-2025-14-4-2203
Views:
8
Email this article 